Analgesic effects of electroacupuncture via the EphBs-p38 MAPK signaling pathway and microglial suppression in the chronic constriction injury rat model of neuropathic pain

Abstract

Objective:

To explore the analgesic effects of electroacupuncture (EA) and its impact on the EphBs-p38 mitogen-activated protein kinase (MAPK) pathway and microglia in a rat model of neuropathic pain (NP).

Methods:

Following adaptive training, 60 male Sprague Dawley (SD) rats were allocated to one of two experiments. In experiment 1, rats received intrathecal SB203580 (p38 MAPK inhibitor), intramuscular EphB1-Fc (EphBs inhibitor) or no injection before undergoing chronic constrictive injury (CCI). In experiment 2, CCI model rats received EA either alone or combined with either anisomycin (p38 MAPK agonist) or EphrinB1-Fc (EphBs agonist) versus minimal acupuncture (MA) as a control intervention. A sham surgery group was included in both experiments as a control for CCI. All groups consisted of n = 6 rats (four in experiment 1 and six in experiment 2). Behavioral hyperalgesia was examined and the spinal L5-6 region was harvested and subjected to enzyme-linked immunosorbent assay to assess tumor necrosis factor (TNF)-α and interleukin (IL)-1β levels. Western blotting and immunofluorescence were used to assess protein expression of B-cell lymphoma (Bcl)-2, Bcl-2 associated X-protein (BAX), EphB1, EphrinB1, p38 MAPK, phosphorylated (p)-p38 MAPK and ionized calcium binding adaptor molecule (Iba)-1.

Results:

CCI induced behavioral hyperalgesia, as demonstrated by altered paw withdrawal latency (PWL), paw withdrawal threshold (PWT) and cytokine levels, and increased p38 MAPK phosphorylation and microglial activation. However, inhibitors SB203580 and EphB1-Fc reversed these effects. Notably, EA showed similar beneficial effects, but these were counteracted when combined with anisomycin and EphrinB1-Fc.

Conclusions:

The analgesic effects of EA in this rat model of NP appear to be linked to diminished p-p38 MAPK expression and subsequent microglial deactivation. EA has a potential role as a complementary therapy for NP.

Keywords

electroacupuncture EphBs microglia neuropathic pain p38 mitogen-activated protein kinase

Get full access to this article

View all access options for this article.

References

Dong

Zhang

Luo

. Association between P2X3 receptors and neuropathic pain: as a potential therapeutic target for therapy. Biomed Pharmacother 2022; 150: 113029.

Zilliox

. Neuropathic Pain. Continuum 2017; 23: 512–532.

Finnerup

Attal

Haroutounian

, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015; 14: 162–173.

Tan

, et al. The role of saponins in the treatment of neuropathic pain. Molecules 2022; 27: 3956.

Jensen

Finnerup

. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol 2014; 13(9): 924–935.

Tsuda

Koga

Chen

, et al. Neuronal and microglial mechanisms for neuropathic pain in the spinal dorsal horn and anterior cingulate cortex. J Neurochem 2017; 141(4): 486–498.

Tozaki-Saitoh

Tsuda

. Microglia-neuron interactions in the models of neuropathic pain. Biochem Pharmacol 2019; 169: 113614.

Zhou

Peng

, et al. Microglia are indispensable for synaptic plasticity in the spinal dorsal horn and chronic pain. Cell Rep 2019; 27: 3844–3859.

Lin

Zhang

, et al. Quercetin alleviates neuropathic pain in the rat CCI model by mediating AMPK/MAPK pathway. J Pain Res 2021; 14: 1289–1301.

10.

Wang

, et al. Sanguinarine attenuates neuropathic pain by inhibiting P38 MAPK activated neuroinflammation in rat model. Drug Des Devel Ther 2020; 14: 4725–4733.

11.

Huang

Mao

, et al. Cynandione A attenuates neuropathic pain through p38β MAPK-mediated spinal microglial expression of β-endorphin. Brain Behav Immun 2017; 62: 64–77.

12.

Kaur

Bali

Singh

, et al. Ephrin B/EphB in neuropathic pain: role and molecular mechanisms. Fundam Clin Pharmacol 2023; 38: 4–12.

13.

Taylor

Campbell

Nobes

. Ephs and ephrins. Curr Biol 2017; 27: R90–R95.

14.

Ruan

Zhang

, et al. EphrinBs/EphBs signaling is involved in modulation of spinal nociceptive processing through a mitogen-activated protein kinases-dependent mechanism. Anesthesiology 2010; 112(5): 1234–1249.

15.

Cao

Ruan

Ling

, et al. Activation of peripheral ephrinBs/EphBs signaling induces hyperalgesia through a MAPKs-mediated mechanism in mice. Pain 2008; 139: 617–631.

16.

Cui

Guo

, et al. Molecular mechanisms underlying the effects of acupuncture on neuropathic pain. Neural Regen Res 2013; 8: 2350–2359.

17.

Choi

Lee

Lim

, et al. Inhibition of ROS-induced p38MAPK and ERK activation in microglia by acupuncture relieves neuropathic pain after spinal cord injury in rats. Exp Neurol 2012; 236(2): 268–282.

18.

Liang

Qiu

, et al. Electroacupuncture attenuates spinal nerve ligation-induced microglial activation mediated by p38 mitogen-activated protein kinase. Chin J Integr Med 2016; 22(9): 704–713.

19.

Liang

Tang

Song

, et al. Electroacupuncture preconditioning reduces oxidative stress in the acute phase of cerebral ischemia-reperfusion in rats by regulating iron metabolism pathways. Evid Based Complement Alternat Med 2021; 2021: 3056963.

20.

Jin

Zhao

, et al. Peripheral EphrinB1/EphB1 signalling attenuates muscle hyperalgesia in MPS patients and a rat model of taut band-associated persistent muscle pain. Mol Pain 2020; 16: 1744806920984079.

21.

Pan

Chen

, et al. miR-126 suppresses neuronal apoptosis in rats after cardiopulmonary resuscitation via regulating p38MAPK. Hum Exp Toxicol 2020; 39(4): 563–574.

22.

Hylden

Wilcox

. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 1980; 67: 313–316.

23.

Mukai

Uchida

Hirosawa

, et al. Frozen vein wrapping for chronic nerve constriction injury reduces sciatic nerve allodynia in a rat model. BMC Neurosci 2022; 23: 37.

24.

Wang

Liu

Fan

, et al. PKM2 is involved in neuropathic pain by regulating ERK and STAT3 activation in rat spinal cord. J Headache Pain 2018; 19: 7.

25.

Wang

Ding

. LncRNA MALAT1 promotes neuropathic pain progression through the miR‑154‑5p/AQP9 axis in CCI rat models. Mol Med Rep 2020; 21(1): 291–303.

26.

Bennett

Xie

. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33(1): 87–107.

27.

Austin

Moalem-Taylor

. Chronic constriction of the sciatic nerve and pain hypersensitivity testing in rats. J Vis Exp 2012; 61: 3393.

28.

Zhang

, et al. MicroRNA-212-3p attenuates neuropathic pain via targeting sodium voltage-gated channel alpha subunit 3 (NaV 1.3). Curr Neurovasc Res 2019; 16(5): 465–472.

29.

Cheng

Chen

Hsu

, et al. Loganin prevents CXCL12/CXCR4-regulated neuropathic pain via the NLRP3 inflammasome axis in nerve-injured rats. Phytomedicine 2021; 92: 153734.

30.

Tian

Song

Wang

, et al. miR-129-5p alleviates neuropathic pain through regulating HMGB1 expression in CCI rat models. J Mol Neurosci 2020; 70(1): 84–93.

31.

Zhang

Cao

Zhang

, et al. Activation of p38 mitogen-activated protein kinase in spinal cord contributes to chronic constriction injury-induced neuropathic pain. Sheng Li Xue Bao 2005; 57: 545–551.

32.

Kullander

Klein

. Mechanisms and functions of Eph and ephrin signalling. Nat Rev Mol Cell Biol 2002; 3(7): 475–486.

33.

Kania

Klein

. Mechanisms of ephrin-Eph signalling in development, physiology and disease. Nat Rev Mol Cell Biol 2016; 17(4): 240–256.

34.

Chu

Xia

Yang

, et al. Melanocortin 4 receptor induces hyperalgesia and allodynia after chronic constriction injury by activation of p38 MAPK in DRG. Int J Neurosci 2012; 122(2): 74–81.

35.

Sommer

Leinders

Üçeyler

. Inflammation in the pathophysiology of neuropathic pain. Pain 2018; 159(3): 595–602.

36.

Zhang

Jing

Chen

, et al. Ferulic acid alleviates sciatica by inhibiting neuroinflammation and promoting nerve repair via the TLR4/NF-κB pathway. CNS Neurosci Ther 2023; 29(4): 1000–1011.

37.

Wang

Fan

Dai

, et al. Fascin-1 contributes to neuropathic pain by promoting inflammation in rat spinal cord. Neurochem Res 2018; 43(2): 287–296.

38.

Malcangio

. Role of the immune system in neuropathic pain. Scand J Pain 2019; 20: 33–37.

39.

Liu

Zhou

Wang

, et al. TNF-α differentially regulates synaptic plasticity in the hippocampus and spinal cord by microglia-dependent mechanisms after peripheral nerve injury. J Neurosci 2017; 37: 871–881.

40.

Edlich

. BCL-2 proteins and apoptosis: recent insights and unknowns. Biochem Biophys Res Commun 2018; 500: 26–34.

41.

Khan

Shal

Ullah Khan

, et al. Neuroprotective mechanism of ajugarin-I against vincristine-induced neuropathic pain via regulation of Nrf2/NF-κB and Bcl2 signalling. Int Immunopharmacol 2023; 118: 110046.

42.

Song

Cao

, et al. Upregulation and redistribution of ephrinB and EphB receptor in dorsal root ganglion and spinal dorsal horn neurons after peripheral nerve injury and dorsal rhizotomy. Eur J Pain 2008; 12(8): 1031–1039.